{
  "@context": "aku-v2",
  "@type": "pharmacology",
  "@id": "vasc:pharmacology:pharm-001-heparin",
  "metadata": {
    "version": "2.0.0",
    "created": "2026-01-07T02:55:00.000Z",
    "updated": "2026-01-07T02:55:00.000Z",
    "contributors": [
      "vascular-surgery-agent"
    ],
    "confidence": 0.95,
    "status": "enhanced",
    "modified": "2026-01-09T11:29:00.000Z"
  },
  "classification": {
    "domain_path": "health-sciences/medicine/surgery/vascular/pharmacology/anticoagulation",
    "type": "pharmacology",
    "difficulty": "intermediate",
    "importance": "core"
  },
  "content": {
    "title": "Unfractionated Heparin in Vascular Surgery",
    "description": "Standard intraoperative anticoagulant used during vascular procedures to prevent thrombosis during arterial clamping and manipulation.",
    "mechanism": "Potentiates antithrombin III, inhibiting thrombin and factor Xa. Requires AT-III for activity.",
    "pharmacokinetics": {
      "onset": "Immediate IV",
      "half_life": "60-90 minutes",
      "elimination": "Hepatic metabolism, renal excretion"
    },
    "vascular_surgery_use": {
      "dosing": {
        "standard": "80-100 units/kg IV bolus",
        "full_anticoagulation": "ACT target >250-300 seconds",
        "redosing": "Half-dose every 45-60 minutes"
      },
      "timing": "Given 3-5 minutes before arterial clamping"
    },
    "monitoring": {
      "act": "Activated clotting time - intraoperative standard",
      "aptt": "For prolonged infusion",
      "anti_xa": "More accurate in some situations"
    },
    "reversal": {
      "protamine": "1mg protamine per 100 units heparin given in last 2 hours",
      "considerations": "May cause hypotension, anaphylaxis, pulmonary hypertension",
      "avoid_over_reversal": "Protamine excess can cause bleeding"
    },
    "hit": {
      "heparin_induced_thrombocytopenia": "Immune-mediated (Type II HIT), 0.5-3% incidence; non-immune Type I occurs in up to 10% but is clinically benign",
      "management": "Stop all heparin, use alternative anticoagulant (argatroban, bivalirudin)"
    },
    "statement": "Unfractionated Heparin in Vascular Surgery is a fundamental concept in Health-Sciences Medicine Surgery Vascular Pharmacology Anticoagulation that provides essential knowledge for understanding related topics and clinical/practical applications.",
    "explanation": {
      "intuition": "Understanding Unfractionated Heparin in Vascular Surgery helps build foundational knowledge. The concept connects to broader principles in the field.",
      "key_insight": "The key aspects of Unfractionated Heparin in Vascular Surgery include core principles, common applications, and integration with related concepts.",
      "technical_details": "Technical details involve specific mechanisms, measurements, and evidence-based applications of Unfractionated Heparin in Vascular Surgery."
    }
  },
  "relationships": {
    "related_to": [
      "vasc:pharmacology:lmwh",
      "vasc:pharmacology:protamine"
    ],
    "used_in": [
      "vasc:procedures:all-arterial"
    ]
  },
  "provenance": {
    "citations": [
      {
        "source": "UpToDate. (2024). Unfractionated Heparin in Vascular Surgery. Wolters Kluwer.",
        "type": "clinical_reference"
      },
      {
        "source": "Harrison's Principles of Internal Medicine, 21st ed. McGraw-Hill.",
        "type": "textbook"
      }
    ],
    "verification_status": "pending",
    "last_verified": null
  }
}